Galectin Therapeutics (GALT) Other Non Operating Income (2010 - 2026)

Galectin Therapeutics' Other Non Operating Income history runs 9 years deep, the most recent figure standing at $983000.0 for Q1 2026.

• In Q1 2026, Other Non Operating Income rose 4032.0% year-over-year to $983000.0; the TTM figure through Mar 2026 stood at -$2.5 million (down 277.18% YoY), while the FY2025 annual figure was -$3.5 million, down 703.4% from the prior year.
• Other Non Operating Income was $983000.0 for Q1 2026 at Galectin Therapeutics, up from -$221000.0 in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $3.6 million in Q3 2023 to a low of -$2.2 million in Q3 2025.
• Historically, Other Non Operating Income has averaged $105866.7 across 5 years, with a median of -$25000.0 in 2025.
• The sharpest annual moves came in 2025 and 2026: Other Non Operating Income tumbled 1105.5% in 2025, then jumped 4032.0% in 2026.
• A 5-year view of Other Non Operating Income shows it stood at -$280000.0 in 2022, then jumped by 1392.5% to $3.6 million in 2023, then slumped by 41.92% to $2.1 million in 2024, then tumbled by 110.51% to -$221000.0 in 2025, then jumped by 544.8% to $983000.0 in 2026.
• The last three Other Non Operating Income figures came in at $983000.0 (Q1 2026), -$221000.0 (Q4 2025), and -$2.2 million (Q3 2025), per Business Quant data.